Literature DB >> 32515382

Cardiovigilance in COVID 19.

Kamal Kishor1, Rishabh Marwah2, Avinash Anantharaj3, Sanjay Kalra4.   

Abstract

The COVID19 (Corona Virus Disease: pandemic started in 2019) pandemic has created not only a public health problem, but as a clinical challenge as well. To the cardiologist, COVID 19 presents a wide spectrum of possibilities for clinical decision-making intervention and improvement. Cardiac dysfunction has been identified as a risk factor, a prognostic factor, a diagnostic tool, differential diagnosis, a complication of COVID 19, and a side effect of its treatment. Certain cardiotropic drugs have been implicated in the pathogenesis of COVID 19. The risk of transmission of COVID 19 is an occupational hazard which cannot be ignored by cardiologists. This review discusses the need and scope of cardio vigilance in COVID 19 management.

Entities:  

Keywords:  Cardiovascular, Conduction defects, Coronavirus, Diabetes, Heart failure, Myocarditis.zzm321990

Mesh：

Year:  2020        PMID： 32515382     DOI： 10.5455/JPMA.14

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN： 0030-9982            Impact factor:   0.781


  3 in total

Review 1.  The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System.

Authors:  Mohammed S Alqahtani; Mohamed Abbas; Abdullah Alsabaani; Amjad Alqarni; Hussain M Almohiy; Entisar Alsawqaee; Raghad Alshahrani; Shahd Alshahrani
Journal:  Infect Drug Resist       Date:  2022-03-22       Impact factor: 4.003

2.  Acute motor-sensory axonal polyneuropathy variant of Guillain-Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report.

Authors:  Ahmed Maseh Haidary; Sarah Noor; Esmatullah Hamed; Tawab Baryali; Soma Rahmani; Maryam Ahmad; Farahnaz Erfani; Hashmatullah Azimi; Habib Ul Rahman Habib; Gul Ahmad Tahiri; Ramin Saadaat; Abdul Sami Ibrahimkhil; Esmatullah Esmat; Haider Ali Malakzai
Journal:  J Med Case Rep       Date:  2021-07-16

Review 3.  The importance of myocarditis in Covid-19.

Authors:  Katayoun Haryalchi; Sepehr Olangian-Tehrani; Seyed Mohammad Asgari Galebin; Mandana Mansour-Ghanaie
Journal:  Health Sci Rep       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.